Galaxy Securities: the penetration rate of assisted reproduction in China is expected to increase in the future

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

Insilico Medicine (英矽智能) Signs Strategic Drug Discovery Partnership with Takeda (武田制药), Deal Worth Up to US$600 Million

Chinese AI drug discovery company Insilico Medicine (英矽智能) has signed a global strategic collaboration with Japanese pharmaceutical company Takeda (武田制药), with the total potential deal value reaching up to US$600 million. Announced in early July, the agreement marks another milestone in the international commercialization of China's AI-powered drug discovery technologies through collaboration with a leading multinational pharmaceutical company.

Alibaba's Qwen to Power Apple Intelligence in China, Bringing a Chinese Foundation Model into Apple's AI Ecosystem

Alibaba Group (阿里巴巴)'s large language model Qwen (通义千问) will provide core AI capabilities for Apple Intelligence in mainland China, following regulatory approval for Apple's AI services in the country.

China’s AI-Linked Computing Trade Reaches CNY 5.13 Trillion as June Exports Surge

China’s exports rose 27% year on year in U.S.-dollar terms in June, the fastest pace in four months, as global demand for artificial intelligence-related hardware provided a fresh source of support for the country’s export sector.

Drug Farm Raises $55 Million in First Closing of Series D Financing

According to EO (亿欧), Drug Farm (药物牧场) announced on July 13 that it had raised $55 million in the first closing of its Series D financing round.